|View printer-friendly version|
|May 29, 2005 11:27 a.m.|
|Teva Announces Tentative Approval Of Zolpidem Tartrate Tablets|
Jerusalem, Israel, May 29, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Zolpidem Tartrate Tablets, 5 mg and 10 mg. Final approval of this product is anticipated upon expiration of patent protection in October 2006.